These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 34681607)

  • 1. PACAP and VIP Modulate LPS-Induced Microglial Activation and Trigger Distinct Phenotypic Changes in Murine BV2 Microglial Cells.
    Karunia J; Niaz A; Mandwie M; Thomas Broome S; Keay KA; Waschek JA; Al-Badri G; Castorina A
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PACAP and VIP Mitigate Rotenone-Induced Inflammation in BV-2 Microglial Cells.
    Broome ST; Musumeci G; Castorina A
    J Mol Neurosci; 2022 Nov; 72(11):2163-2175. PubMed ID: 35199308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit the production of inflammatory mediators by activated microglia.
    Delgado M; Leceta J; Ganea D
    J Leukoc Biol; 2003 Jan; 73(1):155-64. PubMed ID: 12525573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasoactive intestinal peptide and pituitary adenylyl cyclase-activating polypeptide inhibit tumor necrosis factor-alpha production in injured spinal cord and in activated microglia via a cAMP-dependent pathway.
    Kim WK; Kan Y; Ganea D; Hart RP; Gozes I; Jonakait GM
    J Neurosci; 2000 May; 20(10):3622-30. PubMed ID: 10804204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages: in vitro and in vivo studies.
    Delgado M; Munoz-Elias EJ; Gomariz RP; Ganea D
    J Immunol; 1999 Feb; 162(3):1707-16. PubMed ID: 9973433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit chemokine production in activated microglia.
    Delgado M; Jonakait GM; Ganea D
    Glia; 2002 Aug; 39(2):148-61. PubMed ID: 12112366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptors and transcriptional factors involved in the anti-inflammatory activity of VIP and PACAP.
    Leceta J; Gomariz RP; Martinez C; Abad C; Ganea D; Delgado M
    Ann N Y Acad Sci; 2000; 921():92-102. PubMed ID: 11193883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shedding of membrane-bound CD14 from lipopolysaccharide-stimulated macrophages by vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide.
    Delgado M; Leceta J; Abad C; Martinez C; Ganea D; Gomariz RP
    J Neuroimmunol; 1999 Sep; 99(1):61-71. PubMed ID: 10496178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kappa B and IFN regulatory factor 1 activation.
    Delgado M; Munoz-Elias EJ; Gomariz RP; Ganea D
    J Immunol; 1999 Apr; 162(8):4685-96. PubMed ID: 10202009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PACAP-38 but not VIP induces release of CGRP from trigeminal nucleus caudalis via a receptor distinct from the PAC1 receptor.
    Jansen-Olesen I; Baun M; Amrutkar DV; Ramachandran R; Christophersen DV; Olesen J
    Neuropeptides; 2014 Apr; 48(2):53-64. PubMed ID: 24508136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of microglial CD40 expression by pituitary adenylate cyclase-activating polypeptide is mediated by interleukin-10.
    Kim WK; Ganea D; Jonakait GM
    J Neuroimmunol; 2002 May; 126(1-2):16-24. PubMed ID: 12020953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aging-Induced Modulation of Pituitary Adenylate Cyclase-Activating Peptide- and Vasoactive Intestinal Peptide-Induced Vasomotor Responses in the Arteries of Mice.
    Ivic I; Solymar M; Fulop BD; Hashimoto H; Toth G; Tamas A; Juhasz T; Koller A; Reglodi D
    J Vasc Res; 2017; 54(6):359-366. PubMed ID: 29131060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Backup Mechanisms Maintain PACAP/VIP-Induced Arterial Relaxations in Pituitary Adenylate Cyclase-Activating Polypeptide-Deficient Mice.
    Ivic I; Fulop BD; Juhasz T; Reglodi D; Toth G; Hashimoto H; Tamas A; Koller A
    J Vasc Res; 2017; 54(3):180-192. PubMed ID: 28490016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of interferon (IFN) gamma-induced Jak-STAT1 activation in microglia by vasoactive intestinal peptide: inhibitory effect on CD40, IFN-induced protein-10, and inducible nitric-oxide synthase expression.
    Delgado M
    J Biol Chem; 2003 Jul; 278(30):27620-9. PubMed ID: 12754213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of IFN-gamma-induced janus kinase-1-STAT1 activation in macrophages by vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide.
    Delgado M; Ganea D
    J Immunol; 2000 Sep; 165(6):3051-7. PubMed ID: 10975815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VIP/PACAP oppositely affects immature and mature dendritic cell expression of CD80/CD86 and the stimulatory activity for CD4(+) T cells.
    Delgado M; Reduta A; Sharma V; Ganea D
    J Leukoc Biol; 2004 Jun; 75(6):1122-30. PubMed ID: 15020654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of endotoxin-induced macrophage chemokine production by vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in vitro and in vivo.
    Delgado M; Ganea D
    J Immunol; 2001 Jul; 167(2):966-75. PubMed ID: 11441105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) stimulate interleukin-6 production through the third subtype of PACAP/VIP receptor in rat bone marrow-derived stromal cells.
    Cai Y; Xin X; Shim GJ; Mokuno Y; Uehara H; Yamada T; Agui T; Matsumoto K
    Endocrinology; 1997 Jun; 138(6):2515-20. PubMed ID: 9165043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression localisation and functional activity of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors in mouse ovary.
    Barberi M; Muciaccia B; Morelli MB; Stefanini M; Cecconi S; Canipari R
    Reproduction; 2007 Aug; 134(2):281-92. PubMed ID: 17660238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. STAT1 mediates oroxylin a inhibition of iNOS and pro-inflammatory cytokines expression in microglial BV-2 cells.
    Liu PW; Chen MF; Tsai AP; Lee TJ
    PLoS One; 2012; 7(12):e50363. PubMed ID: 23236370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.